Skip to main content

What Quest Diagnostics's latest 10-Q says: 6 signals

Quest Diagnostics filed its latest 10-Q with the SEC on Jul 23, 2026. It discusses acquisition completed, automation investment and capex increase.

Public (DGX)Hospitals and Health Care10,000+ employeesquestdiagnostics.comLinkedIn

Filed
Jul 23, 2026
Filings
2
Signals
12

10-Q · latest 9

What Quest Diagnostics's 10-Q filings say

  1. 10-Q

    Filed · 6 signals

    SEC EDGAR
  2. 10-Q

    Filed · 6 signals

    SEC EDGAR

Showing 9 of 12 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

Quest Diagnostics earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Launching multi-year, $300M+ 'Project Nova' digital transformation with Epic.Quest is undertaking a massive 5-7 year order-to-cash transformation, deploying Epic's Beaker (LIS), MyChart, and Care Everywhere. This signals significant, long-term IT budget for modernizing systems and improving customer experience, creating opportunities for implementation partners and ancillary tech vendors.
Secured $1B annual revenue joint venture with Corewell Health.Quest is establishing a massive lab services joint venture in Michigan, its largest 'Co-Lab' implementation to date. Scaling operations across Corewell's 21 hospital labs will require significant investment in supply chain, lab analytics, and operational support systems.
Facing $100M revenue headwind from PAMA reimbursement cuts next year.Leadership is bracing for a potential $100 million negative impact from PAMA reimbursement cuts next year. This significant cost pressure makes the company highly receptive to solutions that can offset the loss through cost savings, process optimization, and improved efficiency.
Targeting 3% annual cost savings via 'Invigorate' program using AI & automation.The ongoing 'Invigorate' program aims for 3% annual productivity gains by deploying automation and AI to digitize processes. This creates a clear opening for vendors offering solutions that improve operational efficiency, quality, and productivity with a demonstrable ROI.
Facing rising employee healthcare costs, creating a significant margin headwind.The CFO explicitly identified higher-than-expected employee medical expenses as a 'fairly significant headwind' on margins, costing 40-50 basis points. This quantified pain point makes the company receptive to solutions from benefits consultants, wellness platforms, and healthcare cost containment vendors.
Delivered robust revenue growth of 13.1%, with 6.8% organic growth.The company's strong top-line performance, driven by broad-based demand and acquisitions, significantly outpaces market norms. This financial strength and accelerating growth indicate a healthy company with available budget for new projects and investments.

Signal API · MCP

Track Quest Diagnostics with the Signal API

One POST /v1/companies/enrich call with questdiagnostics.com returns Quest Diagnostics 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"questdiagnostics.com","signal_types":["sec-10q"],"limit":20}'

Same industry

Questions about Quest Diagnostics 10-Q

When did Quest Diagnostics file its latest 10-Q?
Quest Diagnostics filed its latest 10-Q on Jul 23, 2026. The one before it was filed on Apr 22, 2026.
What did Quest Diagnostics disclose in its latest 10-Q?
From the filing dated Jul 23, 2026: SVP Commercial Officer, General Counsel & Director adopt 10b5-1 stock selling plans in Q2 2026
What did Quest Diagnostics say on its recent earnings calls?
Q3 FY2025: Launching multi-year, $300M+ 'Project Nova' digital transformation with Epic. (dated Oct 21, 2025).
Where can I read Quest Diagnostics's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/1022079/000102207926000070/dgx-20260630.htm. This page summarizes what the filing says and links to it.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →